The largest database of trusted experimental protocols

17 protocols using mp5 20f3

1

Dexamethasone and Antibody Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were given a single bolus of dexamethasone (Sigma) by ip injection at the concentration of 10 mg/kg or equivalent amount of vehicle (10% DMSO in PBS) at day 10 pi. Neutralizing monoclonal antibodies including 1μg of anti-IL-6 (Biolegend; clone MP5-20F3) or rat IgG1, κ isotype control (Biolegend; clone RTK2071) in 10 μl PBS, and 5μg of anti-FGF-2 (Millipore; clone bFM-1) or mouse IgG1, κ isotype control (Biolegend; clone MOPC-21) in10 μl PBS were administered to mice by subconjunctival injection at days 8, 10, and 12 pi.
+ Open protocol
+ Expand
2

Induced iTreg Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted naive CD4+CD62L+Foxp3EGFP− T cells (1 × 106/ml) were cultured with plate-bound anti-CD28 (5 μg/ml, Biolegend), anti-CD3 (5 μg/ml, Biolegend), recombinant TGF β1 (5 ng/ml, R&D Systems), with or without murine recombinant IL-4 (10 ng/ml) (Perpotech), anti-IL-4 (11B11, 10 μg/ml) (Biolegend) or anti-IL-6 mAb (MP5-20F3, 10 μg/ml) (Biolegend), mitogen activated protein kinase kinase (MEK) inhibitor PD98059 (50 μM, Sigma-Aldrich) or P38 inhibitor IV (10 μM, Sigma-Aldrich). After 4 days, the induced iTreg cells were analyzed by flow cytometry for Foxp3 expression and intracellular cytokines production and/or re-sorted on the basis of EGFP fluorescence.
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Liver Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions of liver or spleen cells or cultured HSC were incubated with Fc blocking reagent (Biolegend) for 10 min followed by 30 min incubation with fluorescently-conjugated mAbs directed against mouse CD11b (M1/70), CD11c (N418), CD45 (30-F11), F/480 (BM8), Gr1 (RB6-8C5), CD115 (AFS98), and MHC II (M5/114.15.2; all Biolegend). Cells were also tested for expression of Dectin-1 (2A11; Abcam), TLR4 (SA15-21; Biolegend), CD14 (Sa14-2; Biolegend) and TLR2 (6C2; eBiosciences). Human liver NPC and PBMC were stained with mAbs directed against CD45 (HI30), CD14 (M5E2; both Biolegend), or Dectin-1 (259931; R&D). For intracellular cytokine staining, liver NPC were incubated for 4 hours with Brefeldin A (1:1000) before permeabilization of cells and staining using fluorescent conjugated mAbs against murine TNF-α (MP6-XT22;) or IL-6 (MP5-20F3; both Biolegend). Experiments were performed using the LSRII cytometer (BD Biosciences) and analysis was done using FlowJo software (Tree Star).
+ Open protocol
+ Expand
4

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
FITC-, PerCP-Cy5.5-, APC-, and PE-conjugated monoclonal antibodies for CD3 (17A2), CD4 (RM4-5), CD25 (PC61.5), CD11c (N418), CD8 (53-6.7), Foxp3 (FJK-16s), CTLA4 (UC10-4B9), CD80 (16-10A1), CD86 (GL-1), CD40 (1C10), CD40L (MR1), CD103 (2E7), I-A/I-E (M5/114.15.2), IFN-γ (XMG1.2), IL-6 (MP5-20F3), Granzyme B (GB11-Biolegend), Perforin (eBioOMK-D), and IL-10 (JES5-16E3) antibodies were purchased from eBioscience. Before IFN-γ, IL-6, and IL-10 intracellular staining, cells were stimulated with 50 nM PMA (Sigma-Aldrich, St. Louis, MO, USA), 1 µg/ml ionomycin (Sigma-Aldrich), and 1 µM Brefeldin A (eBioscience) for 4.5 h. After surface staining for 30 min, the cells were suspended in Fixation Buffer (eBioscience), and intracellular cytokine staining was performed as described [18] (link).
+ Open protocol
+ Expand
5

ELISA for Mouse IL-6 and TNF-α

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISA analyses for IL-6 and TNF-α were performed as previously described [25 (link)]. Antibodies used were: anti-mouse IL-6 (MP5-20 F3, Biolegend) 0.5 μg/mL; biotin anti-mouse IL-6 (MP5-32C11, Biolegend) 1 μg/mL; anti-mouse TNF-α (R&D systems, AF-410-NA) 0.5 μg/mL; biotin anti-mouse TNF-α (R&D systems, BAF410) 0.25 μg/mL.
+ Open protocol
+ Expand
6

Anti-IL-6 Antibody Glucose Tolerance Test

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice at 8 weeks of age were injected via tail veins with 50 μg anti-IL-6 antibodies (MP5-20F3; BioLegend) or control IgG antibodies (RTK2071; BioLegend) every other day for 10 days, followed by GTT tests at day 12. In the case of Fig. 8e,f, IL-6 neutralization was conducted in mice at 8 weeks of age.
+ Open protocol
+ Expand
7

BM-APC Cytokine Response to Polypeptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM-APCs were plated at 1.5 million cells/ml in Gibco RPMI 1640 medium (Thermo Fisher Scientific, Waltham, MA) supplemented with 10% FBS (HyClone, Logan, UT), 1% penicillin/streptomycin (HyClone, Logan, UT), 1 mM sodium pyruvate, 55 μM 2-mercaptoethanol, and GM-CSF (20 ng/ml; PeproTech, Rocky Hill, NJ) with 300,000 cells per well in a 96-well plate and treated with PLPs. Brefeldin A was added to cells at 2 hours to enhance intracellular cytokine accumulation, and cells were harvested at 6 hours for intracellular staining. BM-APCs were stained for live/dead discrimination with Zombie Green Fixable Viability Kit (BioLegend, San Diego, CA) and blocked with anti-mouse CD16/CD32 (clone 93) and True-Stain Monocyte Blocker (BioLegend, San Diego, CA). For surface staining, BMDCs were incubated with BUV395 anti-CD11b (M1/70, BD), BV421 anti-CD11c (N418, BioLegend, San Diego, CA), phycoerythrin (PE)–Dazzle 594 anti-Ly6C (HK1.4, BioLegend, San Diego, CA), and allophycocyanin-Cy7 anti-(I-A/I-E) (M5/114.15.2, BioLegend, San Diego, CA). For intracellular staining, cells were fixed with BD Cytofix and permeabilized with Perm/Wash Buffer (BD) and then labeled with allophycocyanin anti–IL-12(p40/p70) (C15.6, BD) or PE anti–IL-6 (MP5-20F3, BioLegend, San Diego, CA) in combination with allophycocyanin anti-TNFα (MP6-XT22, BioLegend, San Diego, CA).
+ Open protocol
+ Expand
8

Dexamethasone and Antibody Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were given a single bolus of dexamethasone (Sigma) by ip injection at the concentration of 10 mg/kg or equivalent amount of vehicle (10% DMSO in PBS) at day 10 pi. Neutralizing monoclonal antibodies including 1μg of anti-IL-6 (Biolegend; clone MP5-20F3) or rat IgG1, κ isotype control (Biolegend; clone RTK2071) in 10 μl PBS, and 5μg of anti-FGF-2 (Millipore; clone bFM-1) or mouse IgG1, κ isotype control (Biolegend; clone MOPC-21) in10 μl PBS were administered to mice by subconjunctival injection at days 8, 10, and 12 pi.
+ Open protocol
+ Expand
9

Cytokine Modulation of Cellular Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokines and cytokine-neutralizing antibodies were added to cultures upon plating of the cells and used at the following concentrations in vitro: VEGF165 (12 ng/mL; catalog no. CYF- 336; Prospec-Bio), TNFα (100 ng/mL; catalog no. 31501A; Pepro-tech), IL6 (100 pg/mL; catalog no. 216–16; PeproTech), anti-TNFα (0.4 μg/mL; catalog no. AF410NA; R&D Systems), universal IFNα (100 U; catalog no. 11200-2; R&D Systems), anti-IL6 (1 μg/mL; catalog no. MP5-20F3; BioLegend), LPS (25 ng/mL; catalog no. L4524; Sigma), and CpG (25 ng/mL; Mayo Clinic Oligonucleotide Core facility).
+ Open protocol
+ Expand
10

Assessing Endocytic and Cytokine Profiles of BMDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 2w with regular or high nitrate diet feeding, BMDMs were isolated and cultured as previously described [39] . Endocytic potential of BMDMs was assessed by uptake of fluorescently labeled dextran (ThermoFisher, Sweden). Briefly, BMDMs were cultured in 12-well plate for 24 h then incubated with Alexa Fluor 647-labeled Dextran (1 μg/ml) for 30 min. After washing away the extra dextran with PBS, the cells were detached with 2 mM EDTA. Cells were run in a Gallios flow cytometer (Beckman Coulter, Brea, CA) and analyzed using Kaluza v1.1 software (Beckman Coulter).
The intracellular cytokines of BMDMs was also measured by flow cytometer. Briefly, after 24 h of culture, the cells were first incubated with GolgiPlug (1 µl/ml, BD Biosciences) in complete DMEM for 4 h at 37 °C before incubation with antibodies. Fixation/Permeablization and intracellular staining was conducted using the eBioscience Intracellular Staining Kit and the following antibodies: IL-6 (MP5-20F3, Biolegend), IL-1 beta pro-form (NJTEN3, eBioscience), and TNF alpha (MP6-XT22, Biolegend).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!